In a July 9 memo, the director of the FDA's Center for Biologics Evaluation and Research contended there was not enough ...

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

Science reported that the National Institutes of Health (NIH) director, Jay Bhattacharya, dismissed all members of the agency’s top external advisory body, the Advisory Committee to the Director (ACD) ...

Britain launched a life sciences sector plan on Wednesday to a mixed response from the pharmaceutical industry, which welcomed proposals to boost R&D but warned it would fail to keep firms competitive ...

Britain's life sciences sector plan receives a mixed reception from the pharmaceutical industry. While the strategy aims to boost R&D, industry leaders criticize the lack of resolution on drug pricing ...

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

Firms like Moderna that are rapidly adopting AI and will have a higher mix of AI software robots to humans in the future ...

Human organs-on-chips and organoids offer new alternatives to animals for drug development, but there is still a long way to ...

Spikevax has been fully approved for children ages 6 months through 11 years with high-risk conditions. HealthDay News — Moderna’s COVID-19 vaccine has received full approval from the U.S. Food and ...